Relaxin - 1 humain,, recombinant, exprimé en E. coli , > 95% (SDS- PAGE), poudre LYOPHILISÉE

Code: r2156-25ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Relaxin has been shown to have antifibrotic effects in renal fibroblasts through mechanisms that increase collagenase activity and via TGF-β signaling...


en savoir plus

Votre prix
$593.05 25UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Relaxin has been shown to have antifibrotic effects in renal fibroblasts through mechanisms that increase collagenase activity and via TGF-β signaling.

Relaxin 1 may function in regulating blood pressure, controlling heart rate, and releasing oxytocin and vasopressin

General description

Cell signaling hormone that is prominent in the prostate, and belongs to the insulin superfamily

Physical form

Lyophilized powder containing BSA

Reconstitution

In Phosphate buffered saline solution containing at least 0.1% serum albumin. The concentration should be ≥10 µg/mL

assay>95% (SDS-PAGE)
biological sourcehuman
formlyophilized powder
Gene Informationhuman ... RLN1(6013)
mol wt(Contains two disulfide-linked subunits: A chain ~2.8 kDa B chain ~3.3 kDa)
Quality Level100
recombinantexpressed in E. coli
storage temp.−20°C
suitabilityendotoxin tested
technique(s)cell culture | mammalian: suitable
UniProt accession no.P04808
Ce produit répond aux critères suivants: